首页> 外国专利> Compounds useful as inhibitors of voltage-gated ion channels regulated

Compounds useful as inhibitors of voltage-gated ion channels regulated

机译:可用作电压门控离子通道抑制剂的化合物

摘要

1. Claim 1: a formula compound (1),Among them, each RN is an independent hydrogen or C1-4 non-material substitute, which is replaced by up to two substitutes selected from R1, R4 or R5; X1 is O, s or NRX; P is 0 or 1; Rx is h or R2; X2 is a c1-3 non-material substitute, which can be replaced by up to two substitutes selected from R1, R4 or R5 independently; Z from another set of formulas (2),T is an 8-14-membered aromatic or non-aromatic bicyclic or tricyclic ring, which has 0-5 heteroatoms selected from O, S, N, NH, S (O) or SO2; wherein the T ring is attached to the rest of the molecule through a carbon ring atom; wherein each of Z and T optionally comprises up to 4 substituents independently selected from R1, R2, R3, R4 or R5; R1 is oxo, = NN (R6) 2, = NN (R7) 2, = NN (R6R7),R6 or (CH2) n-Y; n is 0, 1 or 2; Y is halo, CN, NO2, CF3, OCF3, OH, SR6, S (O) R6, SO2R6, NH2, NHR6, N (R6) 2, NR6R8, COOH, COOR6 or OR6; or two R1 in adjacent ring atoms, taken together, form 1,2-methylenedioxy or 1,2-ethylenedioxy; R2 is aliphatic, wherein each R2 optionally comprises up to 2 substituents independently selected from R1, R4 or R5; R3 is a cycloaliphatic, aryl, heterocyclic or heteroaryl ring that optionally comprises up to 3 substituents independently selected from R1, R2, R4 or R5; R4 is OR5, OR6, OC (O) R6, OC (O) R5, OC (O) OR6, OC (O) OR5, OC (O) N (R6) 2, OC (O) N (R5) 2, OC (O) N (R6R5),OP (O) (OR6) 2 OP (O) (OR5) 2 OP (O) (OR6) (OR5)SR6, SR5, S (O) R6, S (O) R5, SO2R6, SO2R5, SO2N (R6) 2, SO2N (R5) 2, SO2NR5R6, SO3R6, SO3R5, C (O) R5, C (O) OR5, C (O) R6, C (O) OR6, C (O) N (R6) 2, C (O) N (R5) 2, C (O) N (R5R6),C (O) N (OR6) R6, C (O) N (OR5) R6, C (O) N (OR6) R5, C (O) N (OR5) R5, C (NOR6) R6, C (NOR6) R5, C (NOR5) R6, C (NOR5) R5, N (R6) 2, N (R5) 2, N (R5R6),NR5C (O) R5, NR6C (O) R6, NR6C (O) R5, NR6C (O) OR6, NR5C (O) OR6, NR6C (O) OR5, NR5C (O) OR5, NR6C (O) N (R6) 2, NR6C (O) NR5R6, NR6C (O) N (R5) 2, NR5C (O) N (R6) 2, NR5C (O) NR5R6, NR5C (O) N (R5) 2, NR6SO2R6, NR6SO2R5, NR5SO2R5, NR6SO2N (R6) 2, NR6SO2NR5R6, NR6SO2N (R5) 2, NR5SO2NR5R6, NR5SO2N (R5) 2, N (OR6) R6, N (OR6) R5, N (OR5) R5, N (OR5) R6, P (O) (OR6) N (R6) 2, P (O) (OR6) N (R5R6),P (O) (OR6) N (R5) 2 P (O) (OR5) N (R5R6)P (O) (OR5) N (R6) 2, P (O) (OR5) N (R5) 2, P (O) (OR6) 2, P (O) (OR5) 2 or P (O) (OR6 ) (OR5);R5 is a cyclopentene, arilo, isocyclic or isocyclic ring, which can optionally include up to three R1 substitutes; R6 is h or propylene, where R6 can optionally include one R7 substitute; R7 is a cyclopentene, arilo, isocyclic or isocyclic ring; and each R7 can optionally include up to two selected substitutes. Independent, from h, colon method o (CH2) N-Z ';Z se selecciona de halo CN NO2 CF3 OCF3 OH S-alif tico S (O) -alif tico SO2-alif tico NH2 N-alif tico N (alif tico) 2 N (alif tico) R8 COOH C (O) O (- R8 is an ammonia protection group, provided that: (1) when X2, x1, Q, and P are together - ch2-o,Then t is not the wreckage of an equation set (3)ii) when: X2, X1, q and p are together -CH2-S-,Then, t is not the wreckage of any formula group (4),B is hydrogen, methyl, n-propyl, isopropyl, allyl, benzene or phenyl.
机译:1.权利要求1的式化合物(1),其中,每个RN是独立的氢或C 1-4非物质取代基,其最多被选自R 1,R 4或R 5的两个取代基取代; X1是O,s或NRX; P为0或1; Rx是h或R2; X2是c1-3的非物质替代物,可以被最多两个分别选自R1,R4或R5的替代物替代;另一组式(2)中的Z,T为8-14元芳族或非芳族双环或三环,其具有0-5个选自O,S,N,NH,S(O)或SO2的杂原子;其中T环通过碳环原子连接至分子的其余部分;其中Z和T各自任选地包含至多4个独立地选自R1,R2,R3,R4或R5的取代基; R1是氧代,= NN(R6)2,= NN(R7)2,= NN(R6R7),R6或(CH2)n-Y; n为0、1或2; Y是卤素,CN,NO 2,CF 3,OCF 3,OH,SR 6,S(O)R 6,SO 2 R 6,NH 2,NHR 6,N(R 6)2,NR 6 R 8,COOH,COOR 6或OR 6;或在相邻的环原子上的两个R 1一起形成1,2-亚甲基二氧基或1,2-亚乙基二氧基; R2是脂族基,其中每个R2任选地包含至多2个独立地选自R1,R4或R5的取代基; R3是脂环族,芳基,杂环或杂芳基环,其任选地包含至多3个独立地选自R1,R2,R4或R5的取代基; R4是OR5,OR6,OC(O)R6,OC(O)R5,OC(O)OR6,OC(O)OR5,OC(O)N(R6)2,OC(O)N(R5)2, OC(O)N(R6R5),OP(O)(OR6)2 OP(O)(OR5)2 OP(O)(OR6)(OR5)SR6,SR5,S(O)R6,S(O)R5 ,SO2R6,SO2R5,SO2N(R6)2,SO2N(R5)2,SO2NR5R6,SO3R6,SO3R5,C(O)R5,C(O)OR5,C(O)R6,C(O)OR6,C(O )N(R6)2,C(O)N(R5)2,C(O)N(R5R6),C(O)N(OR6)R6,C(O)N(OR5)R6,C(O) N(OR6)R5,C(O)N(OR5)R5,C(NOR6)R6,C(NOR6)R5,C(NOR5)R6,C(NOR5)R5,N(R6)2,N(R5) 2,N(R5R6),NR5C(O)R5,NR6C(O)R6,NR6C(O)R5,NR6C(O)OR6,NR5C(O)OR6,NR6C(O)OR5,NR5C(O)OR5,NR6C (O)N(R6)2,NR6C(O)NR5R6,NR6C(O)N(R5)2,NR5C(O)N(R6)2,NR5C(O)NR5R6,NR5C(O)N(R5)2 ,NR6SO2R6,NR6SO2R5,NR5SO2R5,NR6SO2N(R6)2,NR6SO2NR5R6,NR6SO2N(R5)2,NR5SO2NR5R6,NR5SO2N(R5)2,N(OR6)R6,N(OR6)R5,N(OR )R6,P(O)(OR6)N(R6)2,P(O)(OR6)N(R5R6),P(O)(OR6)N(R5)2 P(O)(OR5)N(R5R6 P(O)(OR5)N(R6)2,P(O)(OR5)N(R5)2,P(O)(OR6)2,P(O) (OR5)2或P(O)(OR6)(OR5); R5为环戊烯,芳基,等环或等环,其可任选地包括多达三个R1取代基; R 6是h或丙烯,其中R 6可以任选地包括一个R 7取代基; R7是环戊烯,芳基,等环或等环;每个R7可以选择包含最多两个选定的替代物。与h无关的结肠法o(CH2)NZ'; Z se selecciona de halo CN NO2 CF3 OCF3 OH S-alif tico S(O)-alif tico SO2-alif tico NH2 N-alif tico N(alif tico)2 N(alico tico)R8 COOH C(O)O(-R8是氨保护基团,其前提是:(1)当X2,x1,Q和P在一起时-ch2-o,则t不是残基式(3)ii)时:X2,X1,q和p一起是-CH2-S-,则t不是任何式组(4)的残基,B是氢,甲基,正丙基,异丙基,烯丙基,苯或苯基。

著录项

  • 公开/公告号AR045238A1

    专利类型

  • 公开/公告日2005-10-19

    原文格式PDF

  • 申请/专利权人 VERTEX PHARMACEUTICALS INCORPORATED;

    申请/专利号AR2004P102855

  • 申请日2004-08-09

  • 分类号C07D207/48;C07D209/90;C07D213/75;C07D231/24;C07D231/38;C07D237/22;C07D239/42;C07D239/52;C07D241/20;C07D249/14;C07D261/14;C07D277/36;C07D277/52;C07D277/68;C07D277/82;C07D285/12;C07D307/68;C07D401/12;C07D403/12;C07D405/12;C07D405/14;C07D409/12;C07D413/12;C07D417/12;C07D417/14;C07D513/04;C07C311/44;A61K31/425;A61K31/427;A61K31/433;A61K31/175;A61P25/10;A61P25/00;A61P25/12;

  • 国家 AR

  • 入库时间 2022-08-21 22:18:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号